Isavuconazonium

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 122 publications

Successful Long-Term Use of Isavuconazole in a Tacrolimus-Treated Japanese Kidney Transplant Recipient With Disseminated Cryptococcosis and Probable Invasive Aspergillosis.

Successful Long-Term Use of Isavuconazole in a Tacrolimus-Treated Japanese Kidney Transplant Recipient With Disseminated Cryptococcosis and Probable Invasive Aspergillosis.

Journal: Cureus

Published: February 12, 2026

Necrotizing pneumonia due to blastomycosis: Diagnostic challenges and the emerging role of cell-free DNA testing.

Necrotizing pneumonia due to blastomycosis: Diagnostic challenges and the emerging role of cell-free DNA testing.

Journal: IDCases

Published: November 10, 2025

The Activity of FDA-Approved Prodrug Isavuconazonium Sulfate and Its Major Metabolite Isavuconazole Against Naegleria fowleri.

The Activity of FDA-Approved Prodrug Isavuconazonium Sulfate and Its Major Metabolite Isavuconazole Against Naegleria fowleri.

Journal: Pharmaceutics

Published: September 29, 2025

Pharmacokinetic study of isavuconazonium in human plasma measured by HPLC-MS/MS and its use in healthy Chinese subjects.

Pharmacokinetic study of isavuconazonium in human plasma measured by HPLC-MS/MS and its use in healthy Chinese subjects.

Journal: Bioanalysis

Published: August 19, 2025

Pharmacokinetic Interaction Between Isavuconazole and Rifabutin in a Real-World Setting.

Pharmacokinetic Interaction Between Isavuconazole and Rifabutin in a Real-World Setting.

Journal: Mycoses

Published: August 15, 2025

Graded isavuconazonium sulfate challenge in a patient with hypersensitivity to fluconazole.

Graded isavuconazonium sulfate challenge in a patient with hypersensitivity to fluconazole.

Journal: IDCases

Published: July 29, 2025

Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosis.

Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosis.

Journal: bioRxiv : the preprint server for biology

Published: July 14, 2025

A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori.

A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori.

Journal: PloS one

Published: May 13, 2025

Verruconis gallopava: an isavuconazonium foe.

Verruconis gallopava: an isavuconazonium foe.

Journal: ASM case reports

Published: May 02, 2025

The Effect of Drug-Drug Interactions on the Pharmacokinetics of Isavuconazole: A Comprehensive Review.

The Effect of Drug-Drug Interactions on the Pharmacokinetics of Isavuconazole: A Comprehensive Review.

Journal: Clinical pharmacology : advances and applications

Published: March 25, 2025

FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.

FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.

Journal: Turkish journal of biology = Turk biyoloji dergisi

Published: January 13, 2025

Timely diagnosis and management of Quambalaria cyanescens-induced peritoneal dialysis peritonitis: A rare case highlighting the role of galactomannan testing.

Timely diagnosis and management of Quambalaria cyanescens-induced peritoneal dialysis peritonitis: A rare case highlighting the role of galactomannan testing.

Journal: Medical mycology case reports

Published: January 08, 2025

Showing 1-12 of 122

Last Updated: 04/28/2026